GenMont Biotech

GenMont Biotech EV/FCF

The EV/FCF (Enterprise Value to Free Cash Flow) of GenMont Biotech (3164.TW) as of Oct 24, 2026 is 18.14. In the previous year, EV/FCF (Enterprise Value to Free Cash Flow) was 16.12 — a change of 12.55% (higher).

EV/FCF

18.14

YoY

12.55%

Last updated:

EV/FCF (Enterprise Value to Free Cash Flow) of GenMont Biotech is 2025 18.14 . EV/FCF (Enterprise Value to Free Cash Flow) of GenMont Biotech was 2024 16.12 . It decreases by 12.55% higher compared to the previous year.

The GenMont Biotech EV/FCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/FCF
Date
EV/FCF
Jan 1, 2018
-3.03 TWD
Jan 1, 2019
-3.44 TWD
Jan 1, 2020
-56.02 TWD
Jan 1, 2021
-220.26 TWD
Jan 1, 2022
18.28 TWD
Jan 1, 2023
-1,404.03 TWD
Jan 1, 2024
16.12 TWD
Jan 1, 2025
18.14 TWD
The GenMont Biotech EV/FCF history
YEAREV/FCFYoY
18.14+12.55%
16.12-101.15%
-1,404.03-7,782.22%
18.28-108.30%
-220.26+293.17%
-56.02+1,529.58%
-3.44+13.44%
-3.03-112.24%
24.75-75.50%
101.06-327.40%
-44.44+236.63%
-13.20—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

GenMont Biotech Stock analysis

What does GenMont Biotech do? GenMont Biotech Inc. is a biotechnology company based in Tainan, Taiwan, specializing in the research, development, manufacturing, and sale of probiotic supplements. Its products, including various strains of lactobacillus, target immune support against dust allergies and digestive health. The company operates domestically in Taiwan and internationally, having listed on the stock market in 2003. GenMont Biotech is one of the most popular companies on Eulerpool.

Frequently Asked Questions about GenMont Biotech stock

EV/FCF (Enterprise Value to Free Cash Flow) of GenMont Biotech is 18.14 in 2025.

EV/FCF (Enterprise Value to Free Cash Flow) of GenMont Biotech changed from 16.12 to 18.14, representing a 12.55% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EV/FCF (Enterprise Value to Free Cash Flow) GenMont Biotech since 2006 – with annual values, charts, and detailed analysis.

The EV/FCF ratio measures the enterprise value relative to free cash flow. It captures the true cash-generating ability of a business.

To evaluate EV/FCF (Enterprise Value to Free Cash Flow)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/FCF (Enterprise Value to Free Cash Flow).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/FCF (Enterprise Value to Free Cash Flow)'s GenMont Biotech with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Valuation — GenMont Biotech

P/EP/SEV/EBITP/BP/CFP/FCFPEGEV/RevenueEV/EBITDAEV/FCFEarnings YieldFCF YieldMarket capitalizationEnterprise ValueForward P/EP/TBVShareholder YieldBuyback YieldDiv.-Adj. PEGEV/OCF

All Key Metrics — GenMont Biotech